Search

everythinglearnresearchcommunity

for

Search:↓

Treating hyperprolactinemia can help manage PCOS symptoms.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

More research is needed to understand the long-term benefits of insulin-sensitizing drugs for treating adolescents with PCOS.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Knuckle Acanthosis Nigricans is common in Latin American youth and may indicate early insulin resistance, especially in those with normal weight.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

High levels of androgens during early development may cause PCOS-like symptoms.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Lower SHBG levels may increase the risk of PCOS.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

ARL15 is important for fat cell development and the release of the hormone adiponectin.